OrthoPediatrics (KIDS)
(Delayed Data from NSDQ)
$20.39 USD
-0.33 (-1.59%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $20.35 -0.04 (-0.20%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
KIDS 20.39 -0.33(-1.59%)
Will KIDS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for KIDS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for KIDS
OrthoPediatrics (KIDS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
OrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue Estimates
KIDS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Compared to Estimates, OrthoPediatrics (KIDS) Q4 Earnings: A Look at Key Metrics
OrthoPediatrics (KIDS) Reports Q4 Loss, Misses Revenue Estimates
RxSight, Inc. (RXST) Misses Q4 Earnings Estimates
Other News for KIDS
OrthoPediatrics (KIDS) Launches Innovative 3P Pediatric Hip System
OrthoPediatrics launches 3P Pediatric Plating Platform Hip System
Conestoga Micro Cap Composite Q2 2025 Commentary
OrthoPediatrics Breaks Above 200-Day Moving Average - Bullish for KIDS